The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.
The US Food and Drug Administration (FDA) has issued a new report outlining the agency’s inspection activities during the COVID-19 pandemic and detailing a plan for future inspection activity, including the FDA’s priorities going forward.
In March...
The latest on COVID-19 vaccines/drugs and manufacturing from Lilly, Pfizer, Novavax, CSL, Sinovac, and Sinopharm.
Manufacturing and supply of COVID-19 vaccines and drugs
Lilly To Accelerate Availability of COVID-19 Drugs in India Eli Lilly and...
Moderna, a biopharmaceutical company developing messenger RNA (mRNA) therapeutics and vaccines, has entered into separate agreements with Gavi, a global vaccine alliance, to supply up to 500 million doses of its COVID-19 vaccine and, up to 14...
Moderna, a biopharmaceutical company developing messenger RNA (mRNA) therapeutics and vaccines, has announced an expansion of its manufacturing technology center in Norwood, Massachusetts by more than doubling production and lab space.
The...
Moderna, a biopharmaceutical company developing messenger RNA (mRNA) therapeutics and vaccines, reports that it is making new funding commitments to increase supply of its COVID-19 vaccine at its owned and partnered manufacturing facilities to be...
The US government is looking at options to provide US-made doses of AstraZeneca’s COVID-19 vaccine to India and is funding an expansion of manufacturing capacity for Biological E. Limited (BioE), a Hyderabad, India based vaccine and pharmaceutical...
The European Commission is working with Pfizer and BioNTech, a Mainz, Germany-based immunotherapy company, on a new contract for their COVID-19 vaccine with the aim to deliver 1.8 billion doses to the European Union (EU) for 2021 to 2023.
“The...
The US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) have lifted a pause on the rollout of Johnson & Johnson’s (J&J) COVID-19 vaccine in the US and recommended that the rollout of the vaccine...
The latest on COVID-19 vaccines/drugs and manufacturing from AstraZeneca, Merck & Co., Gilead Sciences, Dr. Reddy’s, Valneva, Inovio, and others.
Manufacturing and supply of COVID-19 vaccines and drugs
AstraZeneca Responds to EU’s Legal...
Sanofi has entered into an agreement with Moderna, a biopharmaceutical company developing messenger RNA (mRNA) therapeutics and vaccines, to provide fill–finish sterile manufacturing services and supply packaging for Moderna’s COVID-19 vaccine in...
Pfizer has acquired Amplyx Pharmaceuticals, a San Diego, California-based biopharmaceutical company developing therapies for people with compromised immune systems susceptible to fungal infections. Financial terms were not disclosed.
Amplyx’s lead...
Merck & Co. has announced goals to achieve carbon neutrality across its operations by 2025 and a 30% reduction in its value-chain emissions by 2030.
Merck says it will achieve carbon neutrality by increasing efficiency, reducing carbon...
A roundup of news from China (BeiGene), Denmark (Novo Nordisk), France (Sanofi), Germany (BMS, Evotec, Merck KGaA), and the US (Moderna).
China
BeiGene Gets OK for Commercial Supply Mfg at Biologics Facility BeiGene, a Beijing-based...
The Biden Administration has announced $1.7 billion in funding from the American Rescue Plan to help states and other jurisdictions address COVID-19 variants.
The original strain of COVID-19 comprises only about half of all cases, according to...
The latest on COVID-19 vaccines/drugs and manufacturing from Lilly, GSK, Moderna, Fujifilm, Novavax, CureVac, the Serum Institute of India, Bharat Biotech, and others.
Manufacturing and supply of COVID-19 vaccines and drugs
Serum Institute of...
